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Abstract
Complementary and alternative medicine (CAM) is frequently used by patients with multiple sclerosis (MS). Some MS
patients experience unexpected improvements of symptoms, which they relate to their use of CAM. The aim of this study
was to obtain knowledge and develop understandings of such self-defined unexpected improvement of MS symptoms. Two
cases were constructed based on documents and 12 qualitative interviews. Our aim was not to make generalisations from the
cases, but to transfer knowledge as working hypotheses. We identified four health-related change processes: the process of
losing bodily competence; the process of developing responsibility; the process of taking control; and the process of choosing
CAM. The patients explained unexpected improvements in their MS symptoms as results of their own efforts including
their choice and use of CAM. In our theoretical interpretations, we found the patients’ redefinition of history, the concept of
treatment and the importance of conventional health care to be essential, and leading to a change of patients’ position
towards conventional health care from recipients to explorers. The explorers can be perceived as boundary walkers
reflecting limitations within the conventional health care system and as initiators regarding what MS patients find useful in
CAM.
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One of the greatest challenges facing conventional
health care today is chronic disease, as the number of
chronically ill persons is constantly rising and many
patients with chronic disease suffer profoundly from
their condition physically, emotionally, socially and
spiritually (Davidhizar, 2001; Kleinman, 1988;
Wagner et al., 2001). Chronic diseases are defined
by the US National Center for Health Statistics as
diseases lasting 3 months or more, and that generally
cannot be prevented by vaccines or cured by
medication, nor do they just disappear. The leading
chronic diseases in developed countries include
arthritis, cardiovascular disease, epilepsy, obesity
and cancer (MedicineNet.com, 2010). During the
course of their chronic disease many patients choose
to try out complementary and alternative medicine
(CAM). The content of the concept of CAM
depends on culture and geography, and changes
over time as the borders between conventional
health care and CAM are constantly changing. The
Cochrane Collaboration defines CAM as:
...a broad domain of healing resources that
encompasses all health systems, modalities and
practices, and their accompanying theories and
beliefs, other than those intrinsic to the politically
dominant health system of a particular society or
culture in a given historical period. CAM includes
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users as preventing or treating illness or promoting
health and well-being. Boundaries between CAM
and within the CAM domain and that of the
dominant health care system are not always sharp
or fixed. (Zollman & Vickers, 1999, p. 693)
InNorwaywherethisstudywasconducted,CAMcan
be provided either by a CAM practitioner operating
outside of the government-funded health care system
or by licensed health personnel (Fønnebø & Launsø,
2009; WHO, 2009). Self-reported use of CAM
among patients varies widely between studies, possi-
blybecauseofdifferentdefinitionsofCAMmodalities
and users (Kristoffersen, Fønnebø, & Norheim,
2008). However, several recent studies demonstrate
an increasing use of CAM among Western patients.
The prevalence of CAM usage have been reported
as higher among women, individuals with higher
education, and individuals with poor self-reported
health (Cohen, Ek, & Pan, 2002; Fønnebø & Launsø,
2009; Hanssen et al., 2005; Kessler et al., 2001). In
the Norwegian context, a recent study among the
general population shows that, ‘‘over the previous
12 months’’, 48.7% of the respondents had received
CAM by CAM practitioners outside of or by health
carepersonnelinsidethehealthcaresystem.Approxi-
mately 18% had received CAM by providers four or
more times ‘‘over the previous 12 months’’. The
highestproportionoffemaleusersofCAMwasfound
in 15 24-year olds (Fønnebø & Launsø, 2009).
CAM usage among the chronically ill tends to be
higher than in the general population (Olsen, 2009).
Studies report frequent use of CAM among patients
with arthritis (82.8 90.5%) (Callahan et al., 2009),
cancer patients in 14 European countries (39%)
(Molassiotis et al., 2005) and among MS patients
(27 100% in different studies) (Olsen, 2009). It has
been argued that this trend suggests a continuing
demand for CAM therapies that will affect health
care delivery for the foreseeable future (Bodeker,
Kronenberg, & Burford, 2007; Kessler et al., 2001).
The choice of CAM has been analysed both as
a positive choice towards CAM and a negative
choice towards the established health care system
(Astin, 1998; Siapush, 1998). Studies have called
positive attention to CAM as a treatment system
framing development of personal responsibility,
control and self-care management of chronic disease
(Foote-Ardah, 2003; Goldstein, 2003; Thorne,
Paterson, Russell, & Schultz, 2002), and a treatment
system facilitating ‘‘holistic’’ treatment including
focus on body, mind and spirit (Astin, 1998;
Siapush, 1998; Sirois & Gick, 2002). Negative
attention has been called to CAM in a safety
perspective because of the unregulated nature of
many CAM products and providers in many coun-
tries (WHO, 2002). Several potential risks related to
patients’ choice and use of CAM have been de-
scribed in the literature: for example, contamination
and negative interactions between herbal products
and pharmaceuticals (Bjelakovic, Nikolova, Gluud,
Simonetti, & Gluud, 2007); refusal of important
conventional treatment and delay of diagnosis
(Malik & Gopalan, 2003); CAM as an economical
burden (Utian, 2005); and problematic notions of
self-healing and hyper-positivity (Broom, 2009).
Some chronically ill patients experience unex-
pected improvements of their symptoms which
they relate to their use of CAM (Ho ¨k, 2009;
Jacobson et al., 2005; Launsø et al., 2006; Lee,
2004). In this article we wanted to explore such
unexpected positive courses of disease because they
can be rich in information and context, and can
illustrate both the unusual and the typical (Patton,
2002; Stake, 1995) regarding patients’ treatment
choices and treatment experiences. ‘‘Unexpected
positive courses of disease’’ were in this study
understood as courses that differ from what was
expected by the patients following poor medical
prognoses and the experience of worsened symp-
toms before the use of CAM. We limited our focus to
CAM-users diagnosed with multiple sclerosis (MS).
MS and CAM
MS is a chronic and progressive neurological dis-
order, which can lead to severe disability. The effects
include negative impacts on physical, emotional and
cognitive functioning. The aetiology of the disease
is unknown (Li et al., 2004; Riise, Nortvedt,
& Ascherio, 2003). In 1996, the United States
National Multiple Sclerosis Society standardised
four subtype definitions: relapsing remitting; secondary
progressive; primary progressive;a n dprogressive relap-
sing MS (Lublin, Reingold, & National Multiple
Sclerosis Society Advisory Committee on Clinical
Trials of New Agents in Multiple Sclerosis, 1996).
The relapsing-remitting subtype is characterised by
unpredictable relapses followed by periods of
months to years of relative remission with no new
signs of disease activity. This describes the initial
course of 85 90% of individuals with MS. Secondary
progressive MS describes around 65% of those with
an initial relapsing-remitting MS, who then begin to
have progressive neurological decline between acute
attacks without any definite periods of remission.
Occasional relapses and minor remissions may
appear. The primary progressive subtype describes
the approximately 10 15% of individuals who never
have remission after their initial MS symptoms
(Miller & Leary, 2007). Primary progressive MS is
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with no, or only occasional and minor, remissions
and improvements. Progressive relapsing MS de-
scribes those individuals who, from onset, have a
steady neurological decline but also suffer clear
superimposed attacks. This is the least common of
all subtypes (Lublin et al., 1996). There is a high
prevalence of MS in many populations all over the
world. In Norway, we have an average prevalence of
125 130 per 100,000 inhabitants (Myhr, 2005).
The sex ratio among adults diagnosed with MS is
two women per one man, irrespective of ethnicity
(Fraser & Polito, 2007).
MS is unpredictable both with respect to
alternating exacerbation and remission of symptoms
and the variant symptom patterns across patients
diagnosed with MS (Kirkpatrick Pinson, Ottens,
& Fisher, 2009; Thorne, Con, McGuinness,
McPherson, & Harris, 2004). Studies show anxiety
for what the future holds (Antonak & Livneh, 1995)
and high levels of depression and uncertainty when
MS is compared to other chronic diseases (Rudick,
Miller, Clough, Gragg, & Farmer, 1992). Results
suggest that MS-related depressive symptoms are a
function of prior disease-related impairment, life
stress and possible escape avoidance coping (Aikens,
Fischer, Namey, & Rudick, 1997). MS patients are
facing the fact that their disease can not be cured by
any known conventional treatment, although for
some patients the progression can be slowed down
medically and a number of secondary symptoms can
be treated (Sørensen, Ravnborg, & Jønsson, 2004).
Many MS patients experience that conventional
disease modifying drugs do little to treat their MS
symptoms, improve functioning or enhance quality
of life (Freeman et al., 2001). The symptomatic
treatments are generally characterised by having only
partial effects on the symptoms and by having a
number of adverse effects (Sørensen et al., 2004).
MS patients may therefore seek different methods
to treat and live better with their MS symptoms
(Freeman et al., 2001). We know from the literature
that MS patients in general are frequent users of
CAM (Apel, Greim, Konig, & Zettl, 2006; Nayak,
Matheis, Schoenberger, & Shiflett, 2003; Schwarz,
Knorr, Geiger, & Flachenecker, 2008). In a review
of the literature, Olsen (2009) found that from 27 to
100% of MS patients reported use of CAM. MS
patients’ choice of CAM and their experiences with
use of CAM need more research (Apel, Greim, &
Zettl, 2007; Marrie, Hadjimichael, & Vollmer, 2003;
Nayak et al., 2003; Olsen, 2009; Pucci, Cartechini,
Taus, & Giuliani, 2004). It has been argued from a
public health perspective that knowledge on pa-
tients’ experiences with CAM is needed to change
the public health care in terms of safeguarding and
optimising patients’ treatment choices regardless of
treatment systems (Bodeker et al., 2007). We have
not found any other research on a group of MS
patients who report that they have experienced
unexpected improvements of their MS symptoms
and relate this to their use of CAM.
Aim and research question
The literature review describes a setting where more
research on chronically ill patients’ choice of CAM,
and these patients’ experiences with what they find
useful in CAM, can be of value both for individual
patients and for the development of public health
care programmes in the future. Our aim with this
study was to obtain knowledge and develop under-
standings based on MS patients’ experiences with
unexpected courses of MS that they relate to their
use of CAM. The research question was: What
characterises courses of MS where patients using
CAM experience unexpected improvements of their
MS symptoms?
Design
We chose to explore the patient-defined unexpected
courses of MS by constructing two cases including
material collected from documents and qualitative
interviews. Yin (2003, pp. 13 14) defines a case
study as an empirical inquiry and a research strategy
that investigates a contemporary phenomenon
within its real-life context, and an especially useful
research strategy when the boundaries between
phenomenon and context are not clearly evident.
Yin points out that the case study benefits from the
prior development of theoretical propositions to
guide data collection and analysis. Case studies
have been used as exploratory, descriptive and
explanatory research, and to generate theory and
initiate change (Blaikie, 2000). The purpose of
presenting our analysis by constructing two cases
as typologies (Weiss, 1994) was to demonstrate the
contexts and complexity of the patients’ self-defined
exceptional courses of MS related to their use of
CAM. We found descriptions that included the
contexts and the complexity of our material to be
essential for the development and discussions of
hypotheses and theoretical perspectives with respect
to our research question. We found case construc-
tion suitable for our material and research question,
as case studies enable comparison and complexity,
and detail of the unusual case to be studied in depth
(Anaf, Drummond, & Sheppard, 2007; Stake,
1995).
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The Registry of exceptional courses of disease
In this study, the users of CAM that have experi-
enced unexpected improvements of their MS were
selected from the Registry of Exceptional Courses
of Disease (in the following referred to as ‘‘the
Registry’’). The Registry was established at the
National Research Center in Complementary and
Alternative Medicine (NAFKAM), Norway in 2002.
The main goal was to create a database available for
researching and voicing patients who have experi-
enced unexpected improvement or worsening of
their disease and relate these experiences to their
use of CAM. Internationally, NAFKAM is the first
research institution to establish a Registry for
patients having experienced exceptional courses of
disease encompassing severe and chronic diseases
such as MS and cancer. Previous approaches to
collecting best cases after the use of CAM have been
limited to cancer and were initiated in the USA and
in Germany (Bu ¨schel et al., 1998; Jacobson et al.,
2005; Lee, 2004). The focus in these settings has
been to research the primary outcome such as
tumour response (Launsø et al., 2006). A need for
an improved understanding of the ways in which
CAM is used by individuals with cancer reporting
exceptional treatment experiences has been demon-
strated in Sweden (Ho ¨k, 2009).
The exceptional courses of disease submitted to
the Registry constitute a self-selected sample of
patients from Norway and Denmark. It is therefore
impossible to establish incidence or prevalence of
being an exceptional patient based on this material.
The patients are informed about the Registry by
patient associations,
1 doctors, alternative practi-
tioners, media, and so forth. In the Registry ‘‘ex-
ceptional courses of disease’’ refer to both best and
worst courses related to use of CAM. In best courses
of disease patients report disease remission, cure,
symptom relief and prolonged survival. In worst
courses of disease patients report severe adverse
reactions, delay of diagnosis and refusal of important
conventional treatment. In best courses of disease,
the patients do not define improvement of their
courses of disease related to the use of CAM as
miracles or spontaneous remissions, although their
exceptional courses of disease can include spiritual
or religious experiences or practices. The term
‘‘miracle’’ implies a relationship to the divine and
thereby to questions of faith (Pawlikowski, 2007;
Stempsey, 2002). ‘‘Spontaneous’’ means something
that occurs naturally and not as a consequence of an
intervention. Thus, spontaneous remissions are
defined as recoveries without reason or cause (Bakal,
2001) and are recognised in many health disorders
(Ledingham & Warrell, 2000).
To be included in the Registry the patient must (a)
have received a medical diagnosis; (b) have experi-
enced unexpected improvement or worsening of the
course of disease; and (c) relate this improvement or
worsening to the usage of CAM. The data material
on each patient in the Registry consists of medical
records, a medical assessment and a registration
form. Some of the patients have attached letters,
notes, books, etc. The courses of disease in the
Registry are assessed by medical doctors. Medically
exceptional courses of disease are defined as courses
that occur with less than 1% probability after the
given conventional treatment based on current
medical knowledge. The Registry constitutes a basis
for research both on the patients’ body of knowledge
and on the medical assessments of the courses of
disease. The medical perspective and the patient
perspective can be perceived as complementary
perspectives underpinning different aspects of a
chronic disease and living with a chronic disease.
In this article we limit our focus to exploring what
characterises exceptional best courses of MS from
the Registry based on the patients’ experiences. MS
patients were chosen between patients diagnosed
with different chronic diseases because they are
frequent users of CAM and their chronic condition
gives them longstanding, extensive treatment experi-
ence both from the conventional health care system
and from their use of different CAM modalities and
providers (Apel et al., 2006; Nayak et al., 2003;
Olsen, 2009; Schwarz et al., 2008). We also chose
MS patients because earlier research initiatives on
unexpected positive courses of disease related to the
use of CAM have been limited to cancer (Bu ¨schel
et al., 1998; Ho ¨k, 2009; Jacobson et al., 2005;
Launsø et al., 2006; Lee, 2004).
The multiple sclerosis (MS) patients in the Registry
As of 31st December 2008, 222 patients were
included in the Registry (68% women, 32% men).
Of these, 58 patients were diagnosed with MS, 36
from Norway (23 women, 13 men) and 22 from
Denmark (16 women, 6 men). The 58 MS patients
ranged in age from 34 to 66 years, with a mean of
50.0 and 44% of patients received higher education.
High level of education among users of CAM has
been identified in several studies (Hanssen et al.,
2005; Marrie et al., 2003; Molassiotis et al., 2005).
The mean number of years since being diagnosed
with MS was 12.2. The mean number of years and
the usage of CAM after the MS-diagnosis was 8.2.
About 44 of the 58 patients used more than one
CAM therapy. The most frequently used CAM
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4
(page number not for citation purpose)
Citation: Int J Qualitative Stud Health Well-being 2010; 5: 5032 - DOI: 10.3402/qhw.v5i2.5032modalities among MS patients in the Registry was
acupuncture (51.7%), reflexology (37.9%) and
nutritional therapy (31%). Thirteen of the 58 MS
patients in the Registry had been using alternative
treatment exclusively over many years.
Sampling and participants
Twelve MS patients (nine women, three men) were
selected in June 2007 for qualitative interviews. The
selection was based on document analysis of
the material in the Registry on each of the patients
focusing on selection criteria for the qualitative
interviews. We wanted a sample of MS patients
that reflected variation in criteria important to
explore our research question: gender, age, level of
education, time since diagnosis, commitment to
CAM before and after the diagnosis, experiences
within conventional health care, use of complemen-
tary treatment or alternative treatment exclusively,
and patients’ reasons for defining their courses of
disease as exceptional. The document analysis
showed great similarities between Norwegian and
Danish patients in those criteria. For practical
reasons such as economy and transcription of inter-
views, we therefore chose to select only Norwegian
MS patients for the qualitative interviews. Twelve
patients received letters of invitation including
practical and ethical information. All of them agreed
to participate in the study. The 12 MS patients
ranged in age from 39 to 55 years. The distribution
of MS subtypes (Lublin et al., 1996) in our interview
material was three patients diagnosed with relapsing
remitting MS, six diagnosed with secondary pro-
gressive MS and three diagnosed with primary
progressive MS. The number of years since being
diagnosed with MS varied from 6 to 21. There are
more MS patients that received higher education in
the interview group than in the group of MS patients
in the Registry (10 out of 12). The patients in the
interview group had been using CAM from 3 to
20 years. The most frequently used CAM modalities
in the interview group was acupuncture (six
patients) and nutritional therapy (six patients),
followed by homoeopathy (four patients), massage
(four patients) and healing (four patients). Nine
of the patients used more than one CAM therapy.
Three of the patients had been using several
alternative treatments and alternative providers
exclusively over several years.
Methods
The choice of research methods is not just a
technical choice, but reflects epistemological issues.
We chose a qualitative design to explore what
characterises courses of MS where patients using
CAM experience unexpected improvements of their
MS symptoms. A qualitative research design can not
provide us with causal explanations or provide causal
links between usage of CAM and health-related
outcomes, although the patients in this study
claimed to have experienced positive effects of
CAM use. A qualitative methodology was chosen
because qualitative studies can contribute to a
deeper understanding and more thorough knowl-
edge of important issues in health and well-being
than quantitative studies, given a situation where we
have limited earlier knowledge of our phenomenon
of interest, and we want to study patients’ experi-
ences with reference to their usage of CAM from a
contextual perspective. Launsø and Rieper (2006)
call attention to the use of qualitative methods in
CAM research because patients using CAM often
have chronic and complex illnesses, and because the
principles of alternative treatment formulated by
CAM practitioners often incorporate the patients’
subjectivity, everyday life and general environment.
Document analysis
The concept of document was limited in this study
to include written texts (Prior, 2003): medical
records, medical assessments, letters from patients
to hospitals and doctors and the Registry’s registra-
tion form. We found the content analysis to be a
suitable approach for our study (Prior, 2008).
Document analysis was in this study first used as a
basis for identifying superior themes in the written
material on MS patients in the Registry as a
foundation for developing research questions.
Thereafter, document analysis was used to develop
sampling criteria for qualitative interviews based on
the selected research question. Finally, some infor-
mation from the documents was used in the case
construction, for example, information of medical
diagnoses and assessments.
Qualitative interviews
Qualitative interviews were used as our main
source of information. We understand in-depth
interviews as interactional, reciprocal and reflexive
processes. Thus, interview data are seen as socially
constructed data, based on the interaction between
researcher and participant (Denzin & Lincoln, 2003;
Kvale, 1996). The in-depth and open-ended inter-
views were performed face-to-face and directed
towards understanding the patients’ perspectives
on their lives, experiences or situations as expressed
in their own words (Minichiello, Aroni, Timewell, &
Alexander, 1990). Main interview themes were:
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patient in conventional health care, doctor patient
communication, use of CAM, patients’ own efforts
and the reasons for defining the disease course as
exceptional. Each interview lasted between 90 and
150 min, and was conducted by the author A.S. and
a research assistant with comprehensive knowledge
of the Registry. The interviews were audio-taped and
transcribed verbatim by a professional transcriber.
Ethical considerations
The Regional Committee for Medical and Health
Research Ethics has granted approval for the Reg-
istry and this research project, and both have been
approved by the Norwegian Data Inspectorate. The
transcriber has signed a written consent to profes-
sional confidentiality. The voluntary participation as
well as participants’ ability to withdraw participation
at any time was emphasised by the researchers both
previous to and during the study. We provided
information about the study aim and the research
procedures, including information about the themes
for the interviews and that all information shared
with the researchers would be confidential. Because
we knew that many of our informants suffered from
their MS, we needed to consider whether the inter-
views were possible to complete. We asked the
patients to take breaks and informed them about
the ability to end the interview anytime they wanted.
We were aware of the difference between therapy
and research in our meetings with the informants.
The two patients referred to in the cases have read
through and approved the presented material.
An ethical concern in this study involved legal
issues related to Norwegian laws, affecting, for
example some MS patients’ use of cannabis, and
patients bringing with them unlicensed medication
from abroad. The Regional Committee for Medical
and Health Research Ethics approved that we could
inform the study participants that we would not
initiate legal proceedings around any cases of possi-
ble violation of laws affecting patients’ use of drugs
or unlicensed medication.
Data analysis
Qualitative interviews and documents were used as
data sources for case construction and a flexible
mode of inquiry (Ellis, 2003). In the description of
methods and material we showed how the selection
of MS patients to be interviewed built on document
analysis of written texts. The first author (AS)
conducted a pilot interview with a patient who we
knew, based on the document analysis would pro-
vide us with a substantial amount of information.
Preliminary analyses of this interview together with
document analysis were used as a basis for develop-
ing the final interview guide. Furthermore, 11
interviews were completed during the period of
July 2007 March 2008. As a first step in the analysis
of the 12 in-depth interviews, the interviews were
coded in NVivo (QSR, 2009) according to the main
interview themes and other important themes emer-
ging in the material based on our interpretations and
research question: expectations of conventional
health care, relinquishing conventional health care,
social network, patients’ criteria for choosing con-
ventional and alternative treatments and treatment
providers, experiences with alternative treat-
ments and practitioners, content of the concepts of
disease and treatment, and processes of knowledge
building and change.
First level of analysis
We worked with two levels in the data analysis. At
the first level we applied a case-focused analysis and
an issue (theme)-focused analysis on the 12 inter-
views. A case-focused analysis makes the researchers
aware of the respondent’s experience within the
context of their lives. An issue (theme)-focused
analysis concerns itself with what could be learned
about specific issues, events or processes (Weiss,
1994). Based on information from documents and
qualitative interviews we constructed the cases Mona
and Anna as typologies. We chose to present varia-
tions and patterns in our material as cases instead of
presenting an analysis based on quotations from the
12 interviews, because we found that the cases better
could visualise the important contextual aspects in
our empirical material (Yin, 2003). We chose to use
Mona and Anna’s courses of MS as cases instead of
constructing ideal types. This implies that all in-
formation in each case is from just one patient
(Weiss, 1994). Anna’s and Mona’s exceptional
courses of MS were chosen as cases among the 12
possible cases because these two courses of MS
reflect both essential differences (commitment to
CAM and use of CAM) and essential main features
(e.g., experiences of loss of body, limitations in
conventional health care and the choice and use of
CAM) in the study’s material. The construction of
the cases is based on the concepts used by the
patients. We here used the inductive analytical
strategy. Anna is diagnosed with secondary progres-
sive MS. Mona has the same diagnosis, described in
her medical journal as remitting with incomplete
remission. In the analysis of documents and inter-
views, we did not find different subtypes of MS to be
essential in regard to our research question.
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improvements of MS symptoms related to patients’
use of CAM’’ within its real-life context. Yin (2003)
argues for this analytical strategy especially when
the boundaries between phenomenon and context
are not clearly evident. We identified themes of the
patients’ experiences with the process of developing
an exceptional course of MS. In the analyses of the
12 qualitative interviews and of documents on the 12
interview persons in the Registry material, we found
that the patients emphasise their life conditions in
many aspects when they explain their self-defined
exceptional best courses of MS. We therefore chose
to illustrate our empirical findings in a context, using
case construction based on information from the
qualitative interviews and written material in the
Registry. We included quotations from the qualita-
tive interviews to illustrate our interpretations.
Because of this contextual perspective, the life
conditions and disease courses in the two cases we
present are interwoven.
Second level of analysis
At the second level of analysis we performed an issue
(theme)-focused analysis (Weiss, 1994) on the two
cases, Mona and Anna, based on the case- and issue
(theme)-focused analyses on the first level. State-
ments from the material were brought to a general
level in order to compare and contrast (Weiss,
1994). We searched for thematic categories and
patterns across the two cases and associations
between phenomena within one case (Spencer,
Ritchie, & O’Connor, 2003).
We did not intend to provide causal links between
treatment and outcomes in our analysis. Our aim
was not to make generalisations from the two cases
the way empirical generalisation is possible in, e.g.,
survey research. We found that the two cases were in
some way congruent. Congruent cases make it
possible to transfer knowledge as working hypoth-
eses (Gobo, 2008). Guba and Lincoln (1989) argue
that transferability depends on similarity, in such a
way that patterns of events that occur in one case
recur in the other.
Results
First level of analysis: the cases Mona and Anna
Mona. She is a 54-year-old woman who was
diagnosed with MS in 1989. Her MS was at the
time of the interview in 2007 characterised by
neurologists as secondary progressive according to
the US National Multiple Sclerosis Society’s subtype
definitions (Lublin et al., 1996). Mona is a com-
mitted user of alternative treatments. She has been
using acupuncture, gestalt therapy, nutritional ther-
apy, homoeopathy, healing, massage, reflexology,
dietary advice, Tibetan medicine, Feldenkrais,
anthroposophical medicine, chelation treatment
and art therapy during her MS course. Mona grew
up with a manic-depressive mother and an alcoholic
father. In her childhood and youth she took on
several duties of caring, not only taking care of her
parents but also her alcoholic neighbour and a friend
who had lost her mother. She married in her early
twenties and had two children. Because of her own
childhood, it was very important for her to be a
resource for her children. In 1989 she was about to
finish her education in arts. At the same time her
marriage was becoming really complicated, and she
and her husband got divorced. Mona had not had
any contact with her mother for 2 years and was in
therapy to enable her to handle her childhood when
her mother died in a dramatic fire: ‘‘It was like
everything at once. I was terribly weary ...I was
about to walk up a hill and didn’t think I would
manage. And I was cold, I was very skinny at the
time, only forty some kilos’’.
Mona had earlier seen a doctor, a healer and a
homoeopath because of her fatigue and her diffuse
symptoms. A friend of Mona, who was a doctor, now
got her hospitalised and within a short time she was
diagnosed with MS. After 3 weeks of hospitalisation
and cortisone treatment she came to home and was
bedridden for several weeks with partial paralyses.
Earlier she had started studies to become a nurse
and during that time she became interested in
anthroposophical medicine that focuses on self-
determination, autonomy and dignity of patients.
This medical philosophy fitted better with Mona’s
way of thinking regarding treatment than what she
learned at nursing school. When she returned home
from the hospital, an alternative practitioner gave her
Bernie S. Siegel’s book Love, Medicine and Miracles
(Siegel, 1988):
There I got confirmation to start my inner work;
visualisations, inner travels, using music, relaxa-
tion. // I told myself that my children should not
have a mother to care for like I have had myself.
My mother didn’t get help from the conventional
health care system except too many tablets with
severe side effects.
After a few weeks Mona decided to stop using
conventional treatment: ‘‘I felt like a diagnosis the
way the specialists talked to me. // I was prescribed
cortisone tablets. // They had nothing else to offer
me, and the side effects were really bad’’.
While still bedridden, she chose to use visualisa-
tion, music therapy and autogenic training, and she
A travel from recipient to explorer
Citation: Int J Qualitative Stud Health Well-being 2010; 5: 5032 - DOI: 10.3402/qhw.v5i2.5032 7
(page number not for citation purpose)gradually improved to the point where she was back
on her feet. During the next 16 years Mona used
alternative treatments exclusively: homoeopathy,
reflexology, acupuncture, massage, art therapy, ge-
stalt therapy, healing, dietary advice, Tibetan med-
icine, Feldenkrais, anthroposophical medicine and
chelation treatment. She found certain combinations
to be helpful: ‘‘Each one needs to find their personal
keys’’.
Mona prioritised spending money on alternative
treatments even though her financial resources were
limited. She emphasised the alternative practi-
tioners’ focus on her individual history and life
situation, which implied that she could take an
active part in the treatment of her MS symptoms.
She had received considerable support from her
ex-husband, her present husband and friends when
times were tough. Mona’s inner work has been
focusing on what worked best for her and
on accepting what was tough and difficult:
To me the diagnosis meant loss   loss of body  
loss of a lot. I got divorced and had financial
problems. MS means a lot of strong anxiety   what
happens inside? I have spent a lot of energy not
wanting to have MS.
Today, she explains her disease with her tough
childhood and youth, and many strains in her adult
life: ‘‘Today I see that heavy mental pressure over
time was what set the MS off, so preventing stress is
my best medicine’’. Mona now constantly works
with her psyche by using several techniques which
she has explored over many years. She has made
changes in her life conditions, eats healthy foods and
has moved to the country side. She has re-married,
does not take on tasks that are too big and works
with creative projects that also contribute to her
inner work with the past.
Sixteen years after the MS diagnosis, in 2005,
Mona chose to contact the conventional health care
system again. Via her social network and the Internet
she had learned about new conventional treatments
used at German hospitals which she found interest-
ing. Since 2005, she has tried out several hospitals
and neurologists to find a doctor that she can
communicate with and who she finds supportive
both in relation to trying out new conventional
MS treatments and in relation to her use of alter-
native treatments. Then, she has chosen a neurolo-
gist and a physician whom she finds supportive. The
neurologist is also educated in acupuncture and has
recommended acupuncture, and a special phy-
siotherapeutic treatment based on an integrated
mind body perspective as supplements to the con-
ventional treatment.
Mona’s disease course is in the process of being
medically assessed in the Registry. Mona herself has
defined her course of MS as exceptional because she
thinks that her condition would have been consider-
ably worse if she had kept on letting herself be
controlled by the doctors and not using alternative
treatments:
I know that my disease course is unusual. // If I
had given away the responsibility and taken
cortisone and let myself be controlled, I would
have been in a totally different place. // If I hadn’t
taken all these alternative therapies and walked the
road I have walked, I would have been in a
wheelchair a long time ago. // In the end we are
our own teachers and masters ...I feel that I’m
starting to own more of my story even though a lot
is still too painful to relate to.
Anna. She is a 49-year-old woman who was diag-
nosed with MS in 1991 at the age of 31. Her MS was
at the time of the interview in 2007 characterised by
neurologists as secondary progressive according to
the United States National Multiple Sclerosis So-
ciety’s subtype definitions (Lublin et al., 1996). She
has not been using any alternative treatments as
much and as long as Mona. She has tried out
acupuncture, nutritional therapy and a special com-
plementary treatment that will be further described.
In 1991, Anna was 31 years old, and had then for
many years, from time to time, had diffuse symp-
toms:
At the age of 13 I was hospitalised   after having
received 13 amalgam fillings within one week a
short time before. I had a really bad headache,
hyper reflexes, and a lot of other strange re-
actions ...Looking back, I am convinced that
the mercury was giving me the problems.
In her youth Anna was an active athlete and was
used to pushing herself physically and mentally. In
1982, she started noticing different symptoms, like
losing the sense of touch. She also had a lot of
sinusitis and throat infections at that time. Today she
sees that as part of what set the MS off. The first
clear symptoms showed up in 1986 when she was
diagnosed with optic nerve inflammation. At that
time she was married, had a child and was working
full time in conventional health care. In 1991 Anna
was diagnosed as having MS after relapses and being
paralysed in one arm. She received cortisone treat-
ment and experienced a very good effect from this
for several years. Her doctors encouraged her to live
as before. Anna grew up with the attitude that ill
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ashamed of getting a diagnosis. She kept the disease
a secret from most of the people around her, had her
second child in 1993, and worked harder than ever
to manage everything she thought she should
manage physically and mentally. Both her children
had physical diseases that took a lot out of her and
her husband was away 80% of the time because of
work. She did her best to live as before but she was
too exhausted for that.
All MS relapses were treated with cortisone for
5 years after the diagnosis before b-interferon was
introduced in 1997. At that time b-interferon was
being tried out at Anna’s hospital:
I had always thought that if my feet got bad, I
could still do theoretical work, but when I realised
that it could influence my vision, I got a bit scared.
So then I let myself be talked into taking
b-interferon, and of course I regret that today
because I got really sick from those medicines.
During the 3 years with b-interferon, she went from
working part time being ‘‘invisibly ill’’ to being 100%
disabled. She experienced paralyses in arms and
legs, and blindness on one eye. She had to use a
catheter and had serious difficulties with concentra-
tion:
And the doctors didn’t stop it ...After almost
three years the doctor who was on duty when I
came in said that ‘‘I am glad it is me who is on
duty, because the whole time I have been against
you taking b-interferon.’’ And no one told me that
they were even discussing it, right? And they had
voted on this. It was 5 against 4 neurologists who
let me get this sick. I was so mad at them that I
could have killed them, right. // In December 2000
I could stop the b-interferon and I regained some
of my self-respect when we agreed to stop. // The
doctors treated me like a patient who could not do
anything herself. // They always just said that
‘‘there is nothing you can do, this just follows its
course,’’ almost like predetermined fate in a way.
But for me that didn’t make sense. As a health
care provider, I thought there is a whole lot that
patients can do themselves.
When she was taking about b-interferon, the doctors
were sorry that she had become so much worse.
They did not think it was because of the treatment,
but rather that the disease had moved into a
progressive phase. They offered to help Anna apply
for a place at a nursing home. She was then 40 years
old.
At this point she got really angry with the doctors
and her situation and decided to do something
herself. She looked up different alternatives and
chose to spend time at a health centre that provided
CAM. She received training and gained new under-
standing of her disease and her situation. She also
received dopamine, noradrenalin, acetylcholine and
serotonin used in a non-conventional way, in addi-
tion to diets and supplements.
It was like coming home, it was fantastic. This
doctor told me the first time she saw me that I was
responsible for my own life, and that I had the
possibility to make changes in living my life with
MS. // Part of the treatment that shocked me was
that they said ‘‘lay down! You are so hyper. You
need to find out how much you can actually
handle,’’ which was very little.
Little by little, with the signal substances, resting and
rethinking her way of living with MS, Anna im-
proved. She found that this treatment met the needs
of both body and soul. To let the brain rest was an
important part of the treatment. She learned that she
had to say ‘‘No’’ from time to time, including to
things that she would have been happy to do. Today
she does not get mentally tired any more, and she
has no more relapses. During Anna’s process of
trying out CAM, in 2002, she and her husband got
divorced. Her husband had a job with a lot of
travelling and their two children had both been ill for
a long time. When Anna’s husband told her that he
was exhausted and that she had to deal with her
situation herself, she found divorcing him was the
best thing to do to handle her life, although she still
regrets the divorce.
After having taken responsibility for her living with
MS and having chosen and used CAM, Anna
experienced great improvement of her MS symp-
toms and quality of life. Based on this, she has
defined her course of disease as exceptional. Anna’s
course of disease has been medically assessed both
by medical doctors in the Registry and by an
external neurologist. The conclusion was that An-
na’s course of disease is medically exceptional
because she did experience great improvement of
several physical symptoms 10 years after the onset of
her MS.
Second level of analysis: identification of
health-related change processes
In our analysis at the second level, we emphasised
exploring both the unique and diverse variations in
the constructed cases, as well as the common
patterns that cut across variations. Mona and Anna’s
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cases differ in commitment to CAM and use of
alternative treatment exclusively versus complemen-
tary. Mona was using alternative treatment even
before she was diagnosed with MS. Over time she
was using a great number of alternative treatments,
and for 16 years she was using alternative treatment
exclusively, handling her MS without using any
conventional treatments or visiting neurologists.
Anna tried out most of the treatments she was
offered in conventional health care over many years.
She then chose a medical doctor outside the
conventional health care system as her treatment
provider. This doctor offered a combination of
conventional and alternative treatment. Despite
these differences, we found that the common pat-
terns in the two cases best explain and add knowl-
edge to a feasible understanding of exceptional best
courses of MS among patients using CAM. We have
earlier argued that the two cases are chosen and
constructed as typologies (Weiss, 1994) because they
are rich in information. They show both essential
differences (commitment to CAM and use of CAM)
and essential main features (e.g., experiences of loss
of body, limitations in conventional health care, and
the choice and use of CAM) in the material of
documents and qualitative interviews.
We identified four common health-related change
processes that can contribute to understanding
patient-defined exceptional best courses of MS: the
process of losing bodily competence; the process of
developing responsibility; the process of taking
control; and the process of choosing CAM. The
conventional health care system can be seen as the
background against which the four processes de-
velop. The processes weave into each other, and can
develop and change over time.
The process of losing bodily competence
Both Mona and Anna experienced that losses of
bodily competence can mean losing their self-image
and positions in their private and work life. They
were living busy lives that demanded bodily compe-
tence and not much time to focus on themselves.
Anna experienced that the loss of bodily competence
was something she was ashamed of and wanted to
hide. This loss was also too much of a strain for her
marriage, as she was not able to take care of the
children adequately with her husband travelling a
lot. Also Mona felt that the loss of bodily compe-
tence reduced her ability to be a good mother,
something that was very important to her because of
her own childhood. In the process of losing bodily
competence, we found the patients’ experience of
the limitations in what the conventional health care
system could offer to help them prevent or handle
their loss of bodily competence to be essential.
Facing their loss of bodily competence and the
limitations in the conventional health care system,
Mona and Anna activated their own efforts by the
processes of developing responsibility and taking
control.
The processes of developing responsibility and taking
control
After a process of losing bodily competence, Anna
and Mona went through a process of developing
responsibility in handling their lives with MS. In this
process they did not focus on the disease only in
terms of treatment. Seen in light of the disease,
Mona and Anna re-assessed their life histories and
identified those conditions which, according to their
understanding, had caused or contributed to their
courses of MS. Mona had experienced a complex
and in many ways painful life story before she was
diagnosed with MS. Anna’s life story is different, but
still with clear traits in common with Mona’s story.
Anna had always expected much from herself and
took on heavy work loads. Both Mona and Anna
point at physical and mental overload over many
years as possible reasons for getting MS. Their own
re-interpretations of the past created the basis for
experiencing their course of MS as a learning
process, which enabled them to work on changing
patterns, habits and lifestyles. The disease was to a
small extent seen as chance or fate, and to a larger
extent seen as a result of their choices and priorities.
Thereby Mona and Anna claim to own and influ-
ence their courses of disease. For Anna, the turning
point in the negative development of her MS came
when she saw a doctor offering complementary
treatment. This doctor told her that Anna herself
was responsible for handling her situation and that in
her case being active in relation to her MS disease
meant to relax more. Anna learnt to actively set
limits, and both Anna and Mona today emphasise
the importance of living a quieter life than before in
order to have a better life with MS. Based on their
experience and knowledge on their life conditions
including the disease, Anna and Mona developed
responsibility for their way of living in the past, the
present and the future. This interpretation of disease
meant that it became a goal for Anna and Mona
to take better care of themselves. Today, Mona has
re-married and moved. More and more she relates to
her life story through her inner work, alternative
treatments and changed life conditions, even though
there is still a lot that she has difficulty relating to. To
be responsible for her situation, including living with
MS, means to be aware of context and history.
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process of taking control. These two processes are
inextricably interwoven. Both Anna and Mona
emphasise that taking control, instead of being
controlled by the doctors, was an important step
on their way to experiencing an exceptional best
course of MS. As MS patients in the conventional
health care system, neither of them was satisfied with
the doctor patient communication or the treatments
they were offered. Mona and Anna have used their
families, friends, the Internet and other sources in
exploring new ways to live a better life with MS. An
important aspect of taking control was the process of
choosing CAM.
The process of choosing CAM
In the process of taking control, Mona and Anna
were actively looking for alternative treatments and
practitioners that could accommodate responsible
patients taking control of their lives with MS. This
included their personal efforts, like Mona’s inner
work. One important reason both for Anna and
Mona to choose CAM was that they had experi-
enced severe side effects from the conventional
treatments which they had been given. Mona focuses
on her previous and ongoing mental processes and
mental work when she today explains her excep-
tional course of MS. Using alternative treatments is
a part of these processes and work. Treatment
choices are not final. Being in control and taking
responsibility means to continually evaluate the
situation, in the way Mona did when she found out
about new conventional treatment and again con-
tacted the conventional health care system after
16 years. For Anna, the use of CAM has changed
her understanding of her disease and her capacity for
activity.
Comprehensive understanding
Our research question was what characterises
courses of MS where patients using CAM experience
unexpected improvements of their MS symptoms.
We traced four health-related change processes in the
empirical material that can lead to an understanding:
the process of losing bodily competence; the process
of developing responsibility; the process of taking
control; and the process of choosing CAM. The
processes weave into each other, and can develop and
change over time. We found that the patients
redefined their history, their living with MS, and
the concept of treatment. They defined what they
found useful in CAM. In these processes of change,
CAM was seen as particularly important as a system
of treatment able to frame and mobilise the patients’
own efforts in coping with their living with MS. The
patients redefined the importance and meaning of
the conventional health care. Their own efforts
became dominant, and actions that could nourish
and strengthen these efforts were chosen and con-
stantly assessed. Supported by what they defined as
useful in CAM, the patients in this study experienced
improvements of their MS symptoms that they
claimed they would not have achieved by using
conventional treatments only.
Discussion
Theoretical understandings of the health-related change
processes
We conducted an inductive, bottom-up analysis,
theorising our empirical findings and interpretations
of what characterises self-defined exceptional
courses of MS in patients using CAM. We linked
the four health-related change processes to theore-
tical concepts that create a foundation for analytical
generalisation. Most MS research has focused on the
physical impact of the disease and not on personal
strategies for living a better life with MS (Kirkpatrick
Pinson et al., 2009; Reynolds & Prior, 2003). Based
on the main themes that emerged in our empirical
analysis, we studied MS patients’ choice and use of
CAM from a theoretical standpoint that could
accommodate patients’ choice and use of CAM as
a personal strategy for living a better life with MS.
We found Antonovsky’s (1979, 1987) central theory
of sense of coherence and the three components
comprehensibility, manageability and meaningful-
ness to be an interesting sociological perspective to
try out, together with Bourdieu’s (1977, 1986)
concepts of capital. If a person believes there is no
reason to persist and confront challenges, if the
person experiences no sense of meaning, he will have
less motivation to cope with stress and diseases. The
concept of ‘‘sense of coherence’’ interacts with a
person’s coping style, social network and financial
assets (Antonovsky, 1979, 1987), ingredients in
Bourdieu’s concepts of capital. Bourdieu (1977,
1986) distinguishes between three types of capital:
economic, social and cultural. Economic capital can
be defined as command over economic resources.
Bourdieu (1986, p. 51) defines social capital as ‘‘the
aggregate of the actual or potential resources which
are linked to possession of a durable network of
more or less institutionalised relationships of mutual
acquaintance and recognition’’. The concept of
cultural capital includes forms of knowledge, skills,
education and advantages that individuals have, and
which influence their position and power in different
social contexts (Bourdieu, 1986).
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In our analysis of the processes of losing bodily
competence, developing responsibility, taking con-
trol and choosing CAM, we found the phenomenon
of redefinition to be essential in our interpretations.
According to Antonovsky (1979, 1987), the limits
for what is meaningful are flexible. After having lived
through the process of losing bodily competence that
includes facing limitations in conventional health
care, the MS patients during the three other
identified health-related change processes redefine
their history and lives with MS, the concept treat-
ment and the importance and meaning of conven-
tional health care. By redefinition the patients
become able to extend their scope of action (Launsø,
1997) and develop new knowledge including know-
ledge of CAM. They individually define what is
meaningful in their choice and use of CAM. The
patients make use of their economic, social and
cultural capital (Bourdieu, 1977, 1986) as a basis for
reflection and choice in coping with their lives with
MS.
The patients redefine their history and their lives with
MS
Living with MS and treating MS symptoms includes
contextual and historical aspects. The MS patients
take the authority ‘‘home’’ and, based on their inner
gyroscope (Riesman, Glazer, & Denney, 2001),
guide themselves in coping with their courses of
disease. The past and the future are interpreted
based on a radical change in the present situation,
and the elements of this trinity are connected to and
constantly influencing each other. The patients work
on taking responsibility thereby making changes in
their way of thinking and acting (Rosenzweig &
Thelen, 1998).
The patients redefine the concept of treatment and define
what they find useful in CAM
The concept of treatment is not understood by the
patients as just a single entity isolated from the
recipient of an intervention and seen as determining
the outcomes. The concept must also include
the patients’ receptivity and readiness. The patients
influence how an intervention is being integrated
and used. They extend their scope of action
and develop vigour based on their own efforts and
achievements, their economic, social and cultural
capital (Bourdieu, 1977, 1986). Included in the
patients’ own efforts is the use of the Internet, social
network, literature and the choice and use of CAM.
When the patients choose to use an alternative
treatment outside the conventional health care
system, they are in a position to define the meaning
of their use of CAM. The choice and use of CAM
modalities and the choice of conventional doctors
and CAM practitioners that include the patients’
own efforts can be perceived as ‘‘the turning point’’
in living a better life with MS. Patient with MS in
this study value both their alternative practitioners
and the alternative treatments, but their main focus
is on CAM as a system of treatment able to frame
and mobilise their own efforts in coping with their
living with MS.
The patients redefine their position from recipient to
explorer
The MS patients’ redefinitions in this study can be
summarised as a redefinition of their position from
Recipient to Explorer. The concept of recipient as
we use it here, signals a passive use of interventions.
The concept of explorer signals that the patients
work on safeguarding their health and life situation
in a new way. Riessman (2003) uses the concept of
explorer quite similar to our use, analysing a patient
with MS who is narrating the story about breaking
the frame of his previous life. We have not found the
concept used to describe a patient’s position in other
studies.
The prerequisite to move from recipient to ex-
plorer is that patients redefine their positions as
patients from a passive ‘‘recipient’’ position to an
active ‘‘explorer’’ position. The patients expand their
universe of knowledge and change their position
within this universe from periphery to centre.
The identified health-related change processes pre-
suppose that the patients develop their capital
(Bourdieu, 1977, 1986) regarding personal habits,
patterns of thought and life patterns from their
experience-based knowledge about living with MS.
Early on in the course of MS, the patients and their
doctor have a common perception of the doctor
being positioned at the centre of the universe
of knowledge related to the treatment of the patients’
MS. As time passes, we see that the patients’ uni-
verse of knowledge expands and the patients place
themselves at the centre of this universe. As CAM
and personal efforts take up more space, the patients
place less emphasis on the medical doctors’ power of
definition, and instead develop their scope of action.
The concept of explorer does not only imply
actions. It is important to understand that the
concept also entails all the social, cultural and
economic capital (Bourdieu, 1977, 1986) needed
for the patients to be able to take responsibility for
and cope with their situation in a new way. Further-
more, it is important that the concept of explorer is
understood neither as normative nor as a factor that
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Explorers are not ideal patients and their way of
handling their disease is not static, but constantly
developing. This development is not created by
conventional health care providers or alternative
practitioners, but by the explorers.
To move from recipient to explorer takes time and
requires personal learning and efforts. As explorers,
the patients take on a considerable responsibility and
wish to be respected as independent authorities with
the competences they have developed. The explorers
make new demands on the conventional health care
system by choosing the conventional and alternative
practitioners they want and the treatments they
consider being the best here and now in their life
with MS. The conventional health care providers
are now used according to the explorers’ reflective
consideration of what different treatments and
providers can contribute to their tool kit. The tool
kit and the universe of knowledge are constantly
being tried out, investigated and re-assessed.
The explorers represent a plurality of heteroge-
neous claims to knowledge and actions in which
science does not have a privileged place. The
explorers search for knowledge that is meaningful
in their everyday life with MS. Furthermore, the
knowledge is selected and its relevance assessed in
relation to the patients’ scope of action and action
capacity at a given time. Laypeople, in their differ-
ential engagement with biomedical knowledge, ac-
cording to McClean and Shaw (2005), seek to
adopt, mimic, critique or rewrite experts’ positions.
We can, in this sense, see the movement in late
modernity towards expert knowledge as highly
individualised knowledge (McClean & Shaw,
2005). The constellation of health identities around
lay experiential models of health and the body can be
understood to reflect the diversity of relations in
a technology-driven, consumer-oriented and media-
saturated society (Fox & Ward, 2006). The rise
of CAM can be seen as evidence that elements of
postmodern culture have arrived at the door of
conventional health care (McQuaide, 2005).
The explorers’ choice and use of CAM can be
analysed both as a positive choice towards CAM
(Foote-Ardah, 2003; Goldstein, 2003; Thorne et al.,
2002) and as a negative choice towards the estab-
lished health care system (Astin, 1998; Siapush,
1998). Patients’ reasons for using CAM should be
taken to account in the future both by decision-
makers in public health care (Bodeker et al., 2007),
and by alternative practitioners to optimise patients’
treatment choices and the quality of treatment both
within and outside the conventional health care
system. Leckridge (2004) proposes a patient-centred
model of delivery of CAM and biomedical care,
which shifts the power from therapists to patients
and regulates products and services irrespective of
CAM or biomedical definitions.
Unexpected courses of MS and coping
Our main focus in the further discussion is on
different empirical and theoretical approaches to
coping and MS. We also focus on CAM and chronic
disease from a patient and public health perspective,
and on methodological aspects of our study. In a
study on MS and coping among users of CAM, Apel
et al. (2007) used a quantitative design and found
that MS patients using CAM were more active in
their coping with their disease than patients who
were not using CAM. Most of the earlier studies on
MS and coping are based on QoL-questionnaires,
and focus on optimising the information and inter-
vention programmes in the conventional health care
system (Bishop, Frain, & Tschopp, 2008; Lode et
al., 2007; McCabe, Stokes, & McDonald, 2009;
Montel & Bungener, 2007). It has been argued that
qualitative research on MS and coping is necessary
to complete the picture of the complexity, flexibility
and evolution of the MS patients’ coping strategies
(Reynolds & Prior, 2003; Thorne et al., 2002).
Earlier qualitative studies have shown successful
coping through proactivity, perspective and control
(Malcomson, Lowe-Strong, & Dunwoody, 2008;
Miller, 1997), through preserving valued roles as,
e.g., mother, and through finding new pursuits that
express earlier skills and interests (Reynolds & Prior,
2003). We see common patterns in these studies and
our study. We found that MS patients’ coping
strategies including the choice and use of CAM are
based on history and context and can be very
complex and interwoven. We will argue that our
study in addition to Apel et al.’s (2007) quantitative
study contribute with in-depth knowledge of what in
CAM the MS patients find useful for coping with
their disease.
In a recent qualitative study focusing on self-
reported successful coping in spite of MS progres-
sion, Kirkpatrick Pinson et al. (2009) found that
confronting the problem, effort or will towards
change, and awareness seem to be very potent
factors to create favourable conditions to help MS
patients cope successfully when using conventional
treatments. Also knowledge about MS and the value
of having strong support from health care providers
are important factors for the 10 women that report
successful coping with MS (Kirkpatrick Pinson et
al., 2009). There are obvious similarities and inter-
esting differences between the central findings in our
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difference is the importance of strong support from
the conventional health care system for successful
coping that Kirkpatrick Pinson et al. found. The
patients in our study, however, have often had
negative experiences with conventional health care.
Instead of coping successfully supported by the
conventional health care system, the patients get
support for coping with their MS symptoms from
their social network, alternative practitioners and
last but not least their own inner work. The patients
in Kirkpatrick Pinson et al.’s study (2009) can be
characterised as compliant patients who succeed
within the conventional health care system, as
opposed to the patients in our study who, based on
their experiences with the conventional health care
system and treatment choices based on these experi-
ences, can be characterised as non-compliant
patients. Regarding Kirkpatrick Pinson et al.’s
(2009) operationalisation of successful coping for
compliant MS patients within conventional health
care we argue, based on our study, in favour of a
theory of successful coping for non-compliant MS
patients which includes the four identified health-
related change processes, redefinition and reposi-
tioning from Recipient to Explorer. These MS
patients take their authority home and activate their
inner gyroscope (Riesman et al., 2001) which is the
restarting point and guideline for these patients’
exploring and coping. We argue that these MS
patients have another and wider pool of experience
and scope of action than the compliant MS patients
because they position themselves as users of both
conventional health care and CAM. Furthermore,
we argue that there is a need for more research on
MS and coping among patients using CAM, because
these patients’ coping strategies as we have seen in
this study can be different from coping strategies
among MS patients that are not using CAM.
Our study and the one by Kirkpatrick Pinson et al.
(2009) can be seen as complementing each other
because they explore coping among MS patients
with different positions in relationship to the con-
ventional health care system and the alternative
treatment field. The two studies also contribute
with different methodological accesses. Kirkpatrick
Pinson et al. based their work on a general and
abstract model for coping (the precursors of change-
model), a theory of pre-defined conditions for
coping with chronic disease which they tested on
MS patients through interviews. In our theoretical
understanding of unexpected courses of MS, the
empirically identified health-related change pro-
cesses are essential for our development of a theory
of coping.
Chronic disease and the use of CAM
We find similarities in respect to our empirical
findings and theoretical approaches in a number of
other studies on chronic disease and the use of
CAM. Studies on different groups of patients with
chronic disease call attention to the importance of
CAM as facilitating active coping behaviour and
enhancing self/other awareness (Cartwright & Torr,
2005; Sollner et al., 2000) and to the meaning of
CAM as a treatment system framing development of
personal responsibility and control (Foote-Ardah,
2003; Goldstein, 2003; Thorne et al., 2002). There
are also studies that point to problems in taking
responsibility and control. Broom (2009) finds that
although patients experience positive impacts of
CAM engagement, like increased feeling of control,
power and individual autonomy within therapeutic
processes, they also experience problematic notions
of self-healing and hyper-positivity, involving restric-
tive notions of self-discipline. Taking responsibility
for the past (appearance of disease or symptoms)
could result in a burdensome responsibility with its
own potential risks for the patients’ mental health
and life quality (Pucci et al., 2004). The patients in
our interview material reflect on such risks, but have
not themselves experienced consequences like this
from taking responsibility and control. Studies on
patient physician relations show, like we found in
our study, that many MS patients have experienced
conflicts in their communication with conventional
health care providers regarding the diagnosis, ex-
planation and treatment of the disease (Clayton,
Rogers, & Stuifbergen, 1999; Miller, 1997; Thorne
et al., 2004).
Furthermore, we have argued that researching and
analysing patient experiences based on their history
and lived context gives new information. Kelly-
Powell (1997) found in her study that decisions to
accept treatment are personalised to correspond
with the patients’ view of themselves within the
context of their life stories. Thorne et al. (2003)
explained how people with chronic disease come to
rely heavily on a skill-base founded on personal
experience with the disease within the context of
their unique lives rather than standardised knowl-
edge alone. Hughner and Kleine (2008) underline
that the ways Western consumers once thought
about health have changed and multiplied in a world
with competing health paradigms. They conclude
that we should not classify health care consumers as
either conventional or alternative. This is in line with
the pragmatic way the explorers try out and re-assess
different conventional and alternative treatments
and treatment providers. From a public health
perspective, it has been argued that political and
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agenda where treatment options would not be
considered complementary or alternative, orthodox
or conventional. All possible contributions should be
evaluated for their promise, and harnessed for the
good of the public’s health (Bodeker et al., 2007).
Methodological aspects
The results are based on a self-selected material on
patient-defined exceptional courses of MS in pa-
tients using CAM. We have hereby limited this study
to extreme or deviant cases (Patton, 2002). The
benefit of this sampling strategy is the unique
information gained about unusual cases that have
been assessed by the patients as exceptional courses
of MS. A weakness can be the lack of generalisability.
Patton (2002) argues that the logic of extreme group
sampling is that extreme cases can be information-
rich cases precisely because, by being unusual, they
can illuminate both the unusual and the typical. This
effect can for instance be recognised in our analysis
of MS patients in the Registry as non-compliant
patients coping with their MS through their choice
and use of CAM, compared to compliant patients
coping with their MS through conventional health
care. Patton (2002) further emphasises that, in
evaluation, lessons may be learned about unusual
conditions or extreme outcomes that are relevant to
improve more typical programmes. One of the
backgrounds of this study was the need for more
research on MS patients’ choice of CAM and their
experiences with use of CAM, both from a patient
perspective and a public health perspective (Apel
et al., 2007; Bodeker et al., 2007; Marrie et al.,
2003; Nayak et al., 2003; Olsen 2009; Pucci et al.,
2004).
In line with Flyvbjerg (2004) and Kvale (1996),
we argue that social research should be problem-
driven and not methodology-driven. We chose to
explore our research question by constructing cases
based on qualitative interviews and written docu-
ments, because we found such a design to enable
comparison and complexity, and detail of the
unusual case to be studied in-depth in a contextual
perspective (Anaf et al., 2007; Stake, 1995; Weiss,
1994). Although a purpose was comparison and
contrasting between cases (Yin, 2003), we here used
the case study methodology particularly to under-
stand the shared phenomenon of interest that can be
discovered through the cases (Stake, 2005; Yin,
2003). We argue that a case study with its contextual
perspective can provide new knowledge of patients’
choice and use of CAM in regard to chronic and
complex illnesses (Launsø & Rieper, 2006).
We found qualitative interviews to be a valuable
source of information because we wanted to explore
a phenomenon of which we had little earlier
knowledge, and where patients’ perspectives and
experiences were the source to new knowledge
(Minichiello et al., 1990). According to the com-
municative elements in the interview, we shall keep
in mind that the patients might use their position as
storytellers to regain lost status and taking centre
stage, justifying their own actions (Riessman, 1990).
The patients in the Registry state clearly that they
comment morally and politically (Williams, 1984)
on the limitations they have experienced in the
conventional health care.
The internal validity in this study is ensured
through approval of the case presentations by the
particular patients, by the researchers reading
through and analysing the data material of all MS
patients in the Registry, applying theoretical
approaches to this material and comparing with
previous studies. The patient interviews were open-
ended and focused on the patients’ self-defined
exceptional courses of disease. The interviewers
had no treatment position within conventional health
care or the alternative treatment field. Through
running dialogues between the authors, we have
ensured that tendencies to verify preconceived inter-
pretations were expressed and processed through
working with falsification of preconceived opinions.
In assessing quality of qualitative studies, we can
ask whether the credibility of our claims made is
supported by sufficient evidence (Seale, 2004).
Qualitative methods can not provide us with causal
explanations or provide causal links between use of
CAM and health-related outcomes. We aimed at
transferring knowledge as working hypotheses,
which can be a valuable contribution to further
research on topics of which we have little earlier
knowledge (Gobo, 2008). Gobo (2004) argues for a
theory of idiographic sampling to support empirical
generalisation in case study research. We used
document analysis of all MS patients in the Registry
to create a sample of patients with unusual courses
of MS after the use of CAM that reflected variation.
We then explored similarities and differences from
this sample in regard to our research question. We
have compared information from the interviews with
information from an amount of written documents
of courses of MS from the Registry. The results have
been presented to closed circles of patient associa-
tions, conventional health care providers, alternative
practitioners, and researchers who recognise our
empirical findings and the theoretical understanding
of our findings. Based on this, we will claim that our
empirical and theoretical interpretations may have
some power as hypotheses. However, the results of
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present need to be further explored through different
research designs to establish evident knowledge of
treatment outcomes and what MS patients find
useful in CAM.
Conclusion
The patients in this study can be perceived as
modern boundary walkers, walking the boundaries
between different treatment systems. The patients
express that they have experienced unexpected
improvements of MS symptoms that they relate to
their own efforts, including their choice and use of
CAM. We argue in favour of a theory of successful
coping for non-compliant MS patients which in-
cludes health-related change processes leading to the
choice and use of CAM, redefinition and reposition-
ing from Recipient to Explorer. The concept of
Explorer implies action, and entails all the social,
cultural and economic capital needed for the
patients to take responsibility for and cope with
their situation. As explorers the patients influence
how an intervention is chosen and used. Taking new
and active positions, constantly assessing and re-
assessing their choices of treatment, the explorers
make new demands on both the conventional health
care system and the alternative treatment field in
terms of positions, communication, decision-making
and knowledge. The public health care, CAM
practitioners and conventional health care providers
need to include knowledge of patients’ reasons for
using CAM and patient-experienced benefits and
disadvantages from CAM use to safeguard and
optimise chronically ill patients’ treatment choices
and well-being in the future.
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